Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
123,180,519
-
Total 13F shares
-
81,144,515
-
Share change
-
-1,724,679
-
Total reported value
-
$948,637,092
-
Put/Call ratio
-
94%
-
Price per share
-
$11.69
-
Number of holders
-
252
-
Value change
-
-$23,676,606
-
Number of buys
-
110
-
Number of sells
-
109
Institutional Holders of CATALYST PHARMACEUTICALS, INC. - COMMON STOCK (CPRX) as of Q3 2023
As of 30 Sep 2023,
CATALYST PHARMACEUTICALS, INC. - COMMON STOCK (CPRX) was held by
252 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
81,144,515 shares.
The largest 10 holders included
BlackRock Inc., DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), STATE STREET CORP, VANGUARD GROUP INC, DIMENSIONAL FUND ADVISORS LP, GEODE CAPITAL MANAGEMENT, LLC, ROYCE & ASSOCIATES LP, NORTHERN TRUST CORP, JACOBS LEVY EQUITY MANAGEMENT, INC, and RENAISSANCE TECHNOLOGIES LLC.
This page lists
254
institutional shareholders reporting positions in this security
for the Q3 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.